Sign in

AbbVie Inc.

ABBV

Share price not shown yet: live market data is not connected. Everything below comes from ABBV’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
39%
rev growth + FCF margin
Revenue growth
+10.4%
TTM vs prior TTM
FCF margin
28.3%
ROE (TTM)
—
TTM NI ÷ avg equity
Net debt
$64.2B
total debt − cash & ST inv.
Dilution (YoY)
+0.0%
negative = buybacks
SBC / revenue
1.5%
TTM revenue
$64.4B

Revenue

$0B$5B$10B$15BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$17B

EPS (diluted)

$0.00$0.50$1.00$1.50$2.00$2.50Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$2.03

Margins

GrossOperating
0%20%40%60%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26

Net income

$0B$1B$2B$3B$4BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$4B

Net margin

0%10%20%30%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’2621%

Free cash flow vs. stock-based comp

FCFSBC
$0B$2B$4B$6B$8BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$3B

Operating cash flow vs. capex

OCFCapex
$0B$2B$4B$6B$8BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$3B

R&D vs. SG&A

R&DSG&A
$0B$2B$4B$6BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$2B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…